List of available information in each column of AqSolDB. حسب Bin Pan (742525)

الموضوعات:

3D Scatter plot of features related to water-soluble materials. حسب Bin Pan (742525)

الموضوعات:

Workflow diagram of the prediction algorithm framework. حسب Bin Pan (742525)

الموضوعات:

The Ishihara test for colourblindness [41] encompasses stimuli that can determine the degree and type of colourblindness a person has. حسب Marcel F. Hinss (14675457)

Model A: Logistic structural model. حسب Abigail A. Lee (19935335)

"…Additionally, higher income slightly predicted decreased HPV vaccine hesitancy. All other latent variables and covariates were not significantly predictive of intent to vaccinate in the overall structural mode. …"

Movement variability conditioned on task outcome. حسب Adam M. Roth (19845864)

Validation of distinct contribution of capsule and hypercapsule-associated HMV in IFA-conferred protection against hvKP infection using a <i>ΔrmpD</i>-K7 mutant. حسب Tingting Wang (123983)

Results of two-way ANCOVA for <i>InR</i> and <i>Thor</i> expression differences by temperature and nutritional state interaction with <i>FoxO</i> as a covariate. حسب Tucker Hopkins (20790529)

(A) Serotonin and (B) Dopamine levels in brain tissues. حسب Hammad Ismail (4227988)

Table 1_Dual variants of uncertain significance in a case of hyper-IgM syndrome: implications for diagnosis and management.docx حسب Nourhen Agrebi (14151222)

"…</p>Methods<p>We present immunological and genetic analysis of a Tunisian patient with two homozygous variants of uncertain significance (VUSs) in the IKBKB and AICDA genes, suspected of causing hyper-IgM and immune deficiency. …"

Estimates of average yearly citations of publications by scholars accused of scientific misconduct by retraction status and time. حسب Giulia Maimone (20833354)

الموضوعات:

Estimates of the average yearly citations per publication (including all publications) by scholar group, misconduct type, and time. حسب Giulia Maimone (20833354)

الموضوعات:

(A and B) ChIP-qPCR analysis of HSF2 binding to the indicated KSHV genomic regions expressed as % of input in KSHV infected latent (A) and lytic (B) cells. حسب Lorenza Cutrone (21144285)

Targeted removal robustness analysis. حسب Fei Wang (19534)

"…TK, SOM, SUE and SALP had significant effects on the bacterial community structure of all three taxa. βNTI increased significantly with increasing differences in TN and ALSP and decreased with increasing differences in salt. …"

The network parameter at different distances. حسب Fei Wang (19534)

"…TK, SOM, SUE and SALP had significant effects on the bacterial community structure of all three taxa. βNTI increased significantly with increasing differences in TN and ALSP and decreased with increasing differences in salt. …"

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer حسب Kaizhao Hu (15670612)

"…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …"

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer حسب Kaizhao Hu (15670612)

"…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …"

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer حسب Kaizhao Hu (15670612)

"…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …"

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer حسب Kaizhao Hu (15670612)

"…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …"

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer حسب Kaizhao Hu (15670612)

"…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …"